Skip to content

Clinical trials

Phase 1 Mesothelioma, Malignant trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mesothelioma, Malignant Phase: Phase 1 Country / region: Australia Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20171
20201
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Active, not recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asbestos Diseases Research Foundation1
Checkpoint Therapeutics, Inc.1
Ikena Oncology1
Multitude Therapeutics Inc.1
Quadriga Biosciences, Inc.1
Treeline Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mesothelioma, Malignant6
Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Head and Neck Neoplasms2
Lung Neoplasms2
Melanoma2
Ovarian Neoplasms2
Adenocarcinoma of Lung1
Anorexia1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.